Donald E. Bobo Jr., CVP, Strategy/Corp Development at Edwards Lifesciences Corp (EW), sold 14,500 shares at $91.01 ($1.3M) on 2024-03-13, disclosed to the SEC on 2024-03-13.
Scheduled sale ($1.3M) by CVP, Strategy/Corp Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2026-04-02 | $1.8M | — | Filing → |
| EW | SELL | 2026-03-02 | $1.9M | — | Filing → |
| EW | SELL | 2026-02-26 | $2.0M | — | Filing → |